Universal Risk Stratification in Stage I–III Cutaneous Melanoma Using 31-gene Expression Profiling: A Single-Center Study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comprehensive Risk Assessment for Stage I–III Cutaneous Melanoma Through 31-Gene Expression Profiling: Insights from a Single-Center Investigation

  • By

  • Daniel B. Gehle

  • Philip W. Morgan

  • Emme M. Fitts

  • Nathaniel L. Hauser

  • Chelsea R. Olson

  • Andrew M. Fleming

  • Julia Pedo Freitas

  • Feng Liu-Smith

  • Simonne S. Nouer

  • Andrew J. Murphy

  • Martin D. Fleming

  • June 1, 2026

Share

Original Source(s)

Universal Risk Stratification in Stage I–III Cutaneous Melanoma Using 31-gene Expression Profiling: A Single-Center Study

  • by Daniel B. Gehle, Philip W. Morgan, Emme M. Fitts, Nathaniel L. Hauser, Chelsea R. Olson, Andrew M. Fleming, Julia Pedo Freitas, Feng Liu-Smith, Simonne S. Nouer, Andrew J. Murphy, Martin D. Fleming

  • June 1, 2026

Related Content

Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

Predicting cancer treatment outcomes using machine learning enabled clinical decision support systems